Colgate-Palmolive Price Target Raised by JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) has received an increase in its price target from analysts at JPMorgan Chase & Co., which was raised from $97.00 to $99.00. This update was shared in a research note distributed to investors on Friday. The new price target suggests a potential upside of approximately 10.06% from the stock's current price, which indicates that JPMorgan has a positive outlook on the company's stock performance.

In addition to this adjustment, other equity research firms have also provided their insights on Colgate-Palmolive. For example, Piper Sandler downgraded their price target from $121.00 to $112.00 but maintained an "overweight" rating. Similarly, StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating. Additionally, Morgan Stanley reduced their target to $104.00 while keeping an "overweight" rating and UBS Group adjusted their price target down to $100.00, issuing a "buy" rating.

A total of nine other analysts have given a "hold" rating, while twelve analysts have classified it as a "buy." Only one analyst has rated the stock as a sell. According to MarketBeat data, the consensus rating for Colgate-Palmolive currently stands at a "Moderate Buy" with an average target price of around $101.72.

Colgate-Palmolive Stock Performance Overview

During midday trading on Friday, Colgate-Palmolive stock experienced a slight decline, down $0.57 to reach a price of $89.95. The trading volume for the day was 587,717 shares, which is notably lower than the average volume of approximately 4.17 million shares. The company’s current financial metrics include a current ratio of 0.92 and a quick ratio of 0.58, alongside a notable debt-to-equity ratio of 13.40. Colgate-Palmolive's stock has fluctuated in the past year, with a low of $85.32 and a high of $109.30. The stock's fifty-day moving average is approximately $89.03, and the two-hundred day moving average is around $94.93.

In terms of financial results, Colgate-Palmolive recently announced its quarterly earnings, reporting $0.91 earnings per share (EPS), which surpassed the analysts' consensus estimate of $0.90 by $0.01. The company reported a net margin of 14.38% and an impressive return on equity of 477.77%. This represents growth from the prior year's earnings of $0.87 EPS. Analysts predict that Colgate-Palmolive will achieve an EPS of 3.75 for the current fiscal year.

Hedge Funds and Institutional Investors' Activity

Recently, several hedge funds have made adjustments to their positions in Colgate-Palmolive. Vanguard Group Inc. increased its holdings by 0.7% in the fourth quarter, owning over 81.3 million shares, which equates to a value under $7.4 billion after acquiring an additional 588,230 shares. State Street Corp has also increased its holdings by 3.8%, owning 48.4 million shares worth approximately $5 billion. Other notable investors include Geode Capital Management, Norges Bank, and Massachusetts Financial Services, who have also increased their stakes in the company. Overall, institutional investors now hold 80.41% of Colgate-Palmolive's stock.

Company Profile

Colgate-Palmolive Company specializes in manufacturing and selling a wide range of consumer products across the globe. The company operates through two key segments: Oral, Personal and Home Care, and Pet Nutrition. Its product offerings include toothpaste, toothbrushes, mouthwash, personal care products like shampoos and soaps, household cleaning items, and pet nutrition products.

Colgate-Palmolive, JPMorgan, Stock